Mr. Schultz received his BA degree from Saint Lawrence University in New York and has nearly 25 years of experience in investor relations, financial communications and media relations. He is currently the Vice President of Investor Relations for GW Pharmaceuticals, the global leader in developing cannabinoid-based pharmaceutical medicines. Prior to GW, Mr. Schultz served as Senior Director of Investor Relations and Corporate Communications at Amarin Corporation, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. He has also served as the Executive Director of the Jackson Hole Center for the Arts, a not-for-profit organization aimed at promoting artistic creativity and education. Mr. Schultz’s extensive investor relations and corporate communications experience also includes senior-level roles at Acusphere, Shareholder.com, Manufacturer’s Services Limited, Wang Global and The ForeFront Group.